“Broad range of subjects, all of which are relevant to everyday haematology work. Very good quality questions (and answers!).”Tweet
London, May 2012
Now in its sixth year, this one day BMJ Masterclass will help you stay up to date with the latest research and developments in haematology.
Next Haematology Update:
- Date: Friday 24th May, 2013
- Start Time: 9.10am
- End Time: 5.10pm
- Location: BMA House, London
- Audience: Consultants, specialty doctors, associate specialist, staff grades, specialist registrars, trainees (ST1-3), FY1/2
- Earn a minimum of 6 hours CPD credits for your revalidation portfolio or appraisal
- Programmes designed by a team of doctors who understand your needs, with a focus on practical advice.
- Fully updated content based on your feedback with take home tips that will help you change your practice
- Get your copy of the essential Haematology course handbook and our ‘track your learning’ document.
- Includes a 6 month subscription to BMJ Best Practice
- Network with your peers and get your questions answered by our expert speakers
- Receive a certificate of attendance as evidence of your learning
Sessions have been completely revised for 2013 and include plenty of new topics based on your feedback. Our expert speakers will discuss the latest advances, evidence and guidelines relating to a wide spectrum of malignant and non-malignant conditions. With interactive sessions, case based discussions and time to get your questions answered; this Masterclass will provide you with all the latest information and take home messages to bring your practice up to date.
Course is approved by the Federation of the Royal College of Physicians for 6 category 1 (external) CPD credit(s)
Haematology Programme: Friday 24th May 2013, London
REGISTRATION AND REFRESHMENTS
Welcome and introduction by the Chair Dr Drew Provan
Investigation of suspected haematological malignancy with Dr Chris McNamara
In the opening session our speaker will cover the diagnostic approach to patients with suspected haematological malignancy and the discussion will include:
Myeloma with Professor Jamie Cavenagh
During this session, our expert speaker will provide an overview of multiple myeloma, including:
Myeloproliferative disorders with Dr Anna Godfrey
This session will focus on the major developments in the myeloproliferative neoplasms in the last five years, with a particular focus on:
Lymphoma with Professor David Linch
This session will outline the major advances that have been made in the management of lymphomas over the past five years, with regard to the development of:
The speaker will highlight how these advances are making individualised therapy a realistic prospect.
A non promotional, educational symposium, organised and funded by BMS and Pfizer
Anticoagulation in venous thromboembolism treatment: evolving management with Dr Peter Rose and Dr Ander Cohen
Dr Rose will provide an overview of the current guidelines, pathways and clinical practice for the acute treatment of venous thromboembolism (VTE) and extended treatment for the prevention of recurrent DVT and PE. Dr Cohen will provide a comprehensive review of the existing data and recent developments in the treatment of acute VTE and prevention of recurrent DVT and PE. The mainstay of treatment has been initial use of parenteral anticoagulants followed by longer term use of oral vitamin K antagonists. With the recent development of novel oral anticoagulants, Dr Cohen will transport the audience through the existing data and new developments in the management of this condition.
Haemophilia and von Willebrand disease (vWD) with Dr David Keeling
During this session our speaker will provide an overview of the clinical features and treatment of haemophilia and vWD. They will also discuss:
Obstetric haematology with Professor Beverley Hunt
In this session there will be an opportunity for you to learn about current practice in the management of:
Transfusion medicine with Dr Shubha Allard
Although blood transfusion is an essential part of modern medical and surgical practice, the safety, availability, cost, and clinical indications remain controversial. The speaker will give an update on:
Summary and closing remarks
London – BMA House
Tavistock Square, London, WC1H 9JR
Friday 24 May 2013
|Fee (Incl. of VAT)||Early bird fee||Full fee|
|BMA member/Previous BMJ Masterclass attendee*||£195||£220|
|Trainee doctor/GP trainee/Recently qualified doctor||£170||£195|
Prices are per delegate, per day.
*To book at the previous BMJ Masterclass attendee rate you will need to enter your discount code, which has been sent to the email address used to make your previous BMJ Masterclass booking. To be reminded of your discount code please email our customer service team [hyperlink to firstname.lastname@example.org] or call 0207 111 1106 who will be able to verify your previous attendance.
Dr Drew Provan
Senior Lecturer in Haematology, Barts and The London School of Medicine and Dentistry, London, and Editor, ABC of Clinical Haematology
Drew Provan is a general haematologist with a specific interest in immunohaematology. He is currently Senior Lecturer in Haematology at Bart's & The London School of Medicine and Dentistry. He studied molecular genetics at Leicester University before studying medicine. After junior medical posts in Scotland, Nottingham and Yorkshire, in 1993 he went to the Dana-Farber Cancer Institute in Boston, on an American travelling fellowship awarded by the Medical Research Council. He took up the post of consultant haematologist in Southampton in 1995, and moved to Barts & The London in 2000. He enjoys writing and editing and has been involved in the production of a number of books, including MRCP and MRCPath examination books, in addition to Molecular Haematology (Blackwell Science), Oxford Handbook of Clinical Haematology and Oxford Handbook of Clinical & Laboratory Investigation, and the ABC of Clinical Haematology (BMJ books).
Dr Chris McNamara
Consultant Haematologist, The Royal Free Hospital, London
Dr Chris McNamara is a consultant haematologist with an interest in lymphoma and laboratory diagnostics. He is particularly interested in the interface between the haematology laboratory and the patient and how improvements in the way laboratories operate may improve the quality of care provided.
Professor Jamie Cavenagh
Clinical Lead in Haemato-Oncology, Barts and the London NHS Trust, London
Professor Jamie Cavenagh qualified MB BS in 1985 from St Marys Hospital Medical School, London. He trained in clinical haematology at St Georges Hospital, The Royal Marsden Hospital and Barts and The London. He was a Leukaemia Research Fund Scientific Training Fellow from 1992-1994. He is the chairman of the UK Myeloma Forum. He is the author of over 100 peer-reviewed papers, reviews and book chapters. He has a major interest in conducting clinical research into new therapies for haematological cancers.
Dr Anna Godfrey
Clinical Research Fellow, University of Cambridge and Addenbrooke's Hospital, Cambridge
Anna Godfrey is a clinical research fellow at the Department of Haematology, University of Cambridge, and is in the final year of her PhD with Professor Tony Green. Her research interests focus on the JAK2-positive myeloproliferative neoplasms, especially the factors that contribute to the phenotypes of polycythaemia vera and essential thrombocythemia. She participates in meetings of the NCRI subgroup for MPNs and is involved in the running of the PT-1 trial. Through her work at the Addenbrooke’s Hospital MPN clinic, she is also sub-investigator for the Comfort II trial and will soon be recruiting patients for the MAJIC trial.
Professor David Linch
Professor of Haematology and Head of the Department of Haematology, University College London
Professor David Linch is head of the department of haematology and chairman of the Cancer Research UK Cancer Centre at UCL. He is a founding member of the Academy of Medical Sciences. Professor Linch has been chairman of the National Cancer Research Institute lymphoma clinical studies group and is president of the Lymphoma Association.
Dr David Keeling
Consultant Haematologist, Oxford University Hospitals
David Keeling is a consultant at the Oxford Haemophilia and Thrombosis Centre, which contains a large comprehensive care unit for haemophilia, treating children and adults, an outpatient department for the diagnosis and treatment of deep vein thrombosis and an anticoagulant service. He is secretary to the United Kingdom Haemophilia Centre Doctors' Organisation, chair of the haemostasis and thrombosis task force of the British Committee for Standards in Haematology, a member of the current NICE venous thromboembolism guideline development group and a member of the coagulation steering committee of the UK National External Quality Assessment Scheme.
Professor Beverley Hunt
Professor of Thrombosis and Haemostasis, King’s College, London, Consultant, Departments of Haematology, Pathology and Lupus, Guy’s and St Thomas’ NHS Foundation Trust, London
Beverley Hunt is professor of thrombosis and haemostasis at King's College London and is a consultant in the departments of haematology, pathology and rheumatology. She is also deputy director of research and development at Guy's and St Thomas' Foundation Trust. Professor Hunt has clinical and research interests in thromboprophylaxis, antiphospholipid syndrome, obstetric haematology and perioperative bleeding. She is a co-founder and medical director of the thrombosis charity, ‘Lifeblood', which campaigns to raise awareness of thrombosis. Its current aim is to reduce the risk of hospital-acquired deep vein thrombosis by mandating risk assessment.
Dr Shubha Allard
Consultant Haematologist, Barts & the London NHS Trust and NHS Blood & Transplant and Honorary Clinical Senior Lecturer, Barts and the London School of Medicine, Queen Mary's University of London, London
Dr Allard is a consultant haematologist at Barts and the London NHS Trust and NHS Blood & Transplant. She is also an honorary clinical senior lecturer at Barts and the London School of Medicine, Queen Mary's University of London. She actively promotes the safe and appropriate use of blood and components at local, regional and national level. As a member of the British Committee of Standards in Haematology, she is involved in the development of national guidelines. Dr Allard is an examiner for the Royal College of Pathologists and is actively involved in postgraduate and undergraduate training together with the development of elearning tools. She is chair of the Patient and Public Involvement Group of the CMO's National Blood Transfusion Committee.